MIRA CEO receives 83,500 RSU stock award

MIRA PHARMACEUTICALS, INC. reported an equity compensation award to its Chief Executive Officer, Erez Aminov.

Rhea-AI Filing Summary

MIRA PHARMACEUTICALS, INC. reported an equity compensation award to its Chief Executive Officer, Erez Aminov. On March 30, 2026, he was granted 83,500 restricted stock units (RSUs), each representing the right to receive one share of common stock.

The footnotes state that all of these RSUs vested on the grant date, meaning the award became fully earned immediately. Following this grant, Aminov held 83,500 RSUs directly, with an expiration date of March 30, 2036. This is a compensation-related acquisition, not an open-market stock purchase or sale.

Insider Trade Summary

Grant/Award: 83,500 shares

Grant/Award 1 txn

Insider Aminov Erez

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	83,500	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 83,500 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a right to receive one share of Issuer's common stock.
2. F2. The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. All of the RSU shall vested on the Grant Date.

Key Figures

RSUs granted: 83,500 units Underlying shares: 83,500 shares Grant price: $0.0000 per unit +5 more

8 metrics

RSUs granted 83,500 units Restricted Stock Units granted on March 30, 2026

Underlying shares 83,500 shares Each RSU equals one share of common stock

Grant price $0.0000 per unit Equity compensation award, not a market purchase

Total RSUs after grant 83,500 units Total shares following transaction held directly

Transaction code A Grant, award, or other acquisition of derivative security

Expiration date March 30, 2036 RSU award expiration

Derivative transactions 1 transaction Derivative transaction count in summary

Acquire transactions 1 acquisition TransactionSummary acquireCount

Key Terms

Restricted Stock Units, Grant Date, vested, derivative security, +1 more

5 terms

Restricted Stock Units financial

"security_title: Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Grant Date financial

"The RSUs were issued to the Reporting Person on the Grant Date"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

vested financial

"All of the RSU shall vested on the Grant Date"

derivative security financial

"transaction_type: derivative"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

underlying security financial

"underlying_security_title: Common Stock"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MIRA (MIRA) report for its CEO?

MIRA reported that CEO Erez Aminov received a grant of 83,500 restricted stock units. These RSUs are a form of equity compensation that give him rights to future common shares rather than reflecting an open-market stock purchase or sale.

How many RSUs did the MIRA (MIRA) CEO receive in this Form 4?

The CEO was granted 83,500 restricted stock units. According to the filing, each unit corresponds to one share of MIRA’s common stock, and his total holdings following the transaction were 83,500 RSUs, all held directly as of the reported date.

Do the granted RSUs for MIRA (MIRA) vest over time or immediately?

The filing states that all of the restricted stock units vested on the grant date. This means the full 83,500-unit award became earned immediately, rather than vesting in installments over several years as many equity awards typically do.

What does each MIRA (MIRA) restricted stock unit represent for the CEO?

Each restricted stock unit represents a right to receive one share of MIRA’s common stock. When the units settle under the company’s plan, the CEO will receive one share per RSU, aligning his compensation directly with the company’s equity.

What is the expiration date of the MIRA (MIRA) CEO’s RSU award?

The RSU award carries an expiration date of March 30, 2036. This date marks the end of the period during which the units can be settled into common shares under the plan terms described in the Form 4 footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 05:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aminov Erez

(Last) (First) (Middle)

C/O MIRA PHARMACEUTICALS, INC.

1200 BRICKELL AVE. SUITE 1950 #1183

(Street)

MIAMI FLORIDA 33131

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MIRA PHARMACEUTICALS, INC. [ MIRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/30/2026		A		83,500		(2)	03/30/2036	Common Stock	83,500	$0	83,500	D

Explanation of Responses:

1. Each restricted stock unit represents a right to receive one share of Issuer's common stock.

2. The RSUs were issued to the Reporting Person on the Grant Date, pursuant to the Plan. All of the RSU shall vested on the Grant Date.

	/s/ Erez Aminov	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)